Bolsonaro’s defense seeks cranial electric stimulation treatment in prison for complex health issues
Former President Jair Bolsonaro’s legal team has formally requested authorization from Brazil’s Supreme Federal Court for him to undergo cranial electric stimulation (CES) sessions within the Papuda Penitentiary Complex. Bolsonaro, 70, is currently serving a sentence at the facility.
The plea, submitted last Friday, the 20th, to Minister Alexandre de Moraes, who oversees penal execution cases, outlines a plan for the ex-president to receive this specialized neuromodulation therapy three times weekly. The proposed treatment would be administered by a qualified psychologist and neuroscientist.
According to his attorneys, Bolsonaro had already commenced this procedure during a hospitalization in April 2025. They assert that the initial sessions yielded noticeable improvements in various symptoms, including chronic insomnia, anxiety, depressive episodes, and persistent bouts of hiccups, which have troubled the former leader.
Understanding cranial electric stimulation: a non-invasive approach
Cranial electric stimulation, commonly known by its acronym CES, represents a non-invasive neuromodulation technique that employs microcurrents of low-intensity electricity to gently stimulate the brain. The procedure is typically painless and involves the application of small clips placed on the earlobes.
The primary objective of CES is to modulate brain activity, aiming to restore the natural balance of neural circuits that govern crucial functions such as mood regulation, sleep patterns, and the overall control of the nervous system. This targeted approach differentiates it from traditional medications, which typically exert systemic effects across the entire body.
Neuromodulation’s role in depression: promising research from USP
Researchers at the University of São Paulo (USP) conducted a rigorous clinical study involving patients diagnosed with depression who had not responded adequately to conventional treatments. The investigation sought to determine whether targeted brain stimulation could reactivate areas of the brain exhibiting reduced function, a condition frequently associated with clinical depression.
Participants in the study received specific rapid brain stimulation sessions, known as theta-burst stimulation. These sessions were administered three times daily over a period of three weeks, with each session lasting approximately six minutes and incorporating controlled intervals between them.
This particular type of stimulation is designed to reorganize the intricate neural circuits responsible for regulating mood. The study’s results provided compelling evidence of its efficacy, demonstrating that:
- 52% of patients who received the active treatment experienced a significant improvement in their depressive symptoms.
- In contrast, the group that received a simulated (sham) treatment reported a 22% improvement.
The research adhered to the highest scientific standards, employing a randomized, controlled, and triple-blind methodology, which is considered the gold standard for clinical trials. The researchers concluded that neuromodulation could serve as an effective complementary therapy for depression, particularly in cases resistant to medication.
Addressing chronic insomnia: studies show potential benefits
Beyond depression, neuromodulation is also extensively studied as a supplementary treatment for insomnia, a prevalent disorder that profoundly impacts brain function and overall well-being. A clinical study published in the Journal of Sleep Research in 2023 explored its application in adults experiencing insomnia symptoms.
In this study, participants utilized a cranial electric stimulation device for 30 minutes, twice daily, over a two-week period. Researchers meticulously assessed various factors, including the subjects’ sleep quality, emotional symptoms, and changes in brain activity.
The findings indicated that participants who actively used the CES device exhibited several positive outcomes:
- A significant reduction in depressive symptoms was observed.
- Improvements in their overall physical well-being were reported.
- Positive alterations in brain activity patterns were detected.
These changes collectively suggest that the CES technique can play a vital role in helping to regulate the brain patterns specifically associated with sleep induction and states of relaxation.
Tackling persistent hiccups: regulating involuntary contractions
Hiccups, medically termed singultus, are caused by involuntary contractions of the diaphragm, a muscle primarily controlled by the nervous system. While typically self-limiting and brief, hiccups can become persistent if they last for more than 48 hours, significantly impairing an individual’s quality of life.
Severe and prolonged cases of hiccups can lead to a range of debilitating issues, including sleep disturbances, unintended weight loss, chronic fatigue, and considerable psychological stress. Traditional treatment often involves medications designed to act on the nervous system, yet not all patients respond favorably to these therapies.
Consequently, techniques that directly stimulate the nervous system, such as neuromodulation, have emerged as a promising alternative. Case studies have indicated that neural stimulation can effectively help regulate the aberrant nerve signals responsible for the involuntary diaphragmatic contractions, thereby reducing both the frequency and intensity of hiccups, particularly in refractory cases.
Complementary care and ongoing judicial review for prison treatment
Neuromodulation is not intended to replace established traditional treatments but rather to serve as a valuable complement, especially in instances where symptoms persist despite conventional medical interventions. The technique’s appeal lies in its non-invasive nature and a notably low risk of adverse side effects, making it an increasingly favored option in both neurology and psychiatry.
Among the key benefits consistently observed across various studies are improvements in sleep quality, a reduction in anxiety levels, alleviation of depressive symptoms, and the overall regulation of brain activity. In the specific case of former President Bolsonaro, his defense maintains that the continuation of CES sessions could prove instrumental in managing his neurological symptoms and enhancing his quality of life, particularly given his documented history of recent neurological alterations. However, the approval of this request remains contingent on judicial authorization from the Supreme Federal Court.
The future of neuromodulation in patient care
As research continues to expand the understanding of brain function and the efficacy of targeted stimulation, neuromodulation therapies like CES are gaining broader acceptance and application in clinical practice. Their potential to offer relief for a spectrum of neurological and psychiatric conditions underscores a growing paradigm shift towards more precise and personalized approaches to patient care.






